DAFTAR PUSTAKA

B. D. Schoub (1999). AIDS and HIV in Perspective: A Guide to Understanding

the Virus and Its Consequences. Cambridge University Press. 57-59.
Bica I, McGovern B, Dhar R (2001). Increasing Mortality Due to End-stage Liver
Disease in Patients with Human immunodeficiency Virus Infection. Clin
Infect Dis 2001;32:492-7.
Brooks, G.F., Butel, J.S., Morse, S.A (2008). AIDS dan Lentivirus. Dalam:
Brooks, Butel, Morse. Jawetz, Melnick, & Adelbergs Mikrobiologi
Kedokteran 23rd Ed. Jakarta: EGC. 617-32.
Michael W. Davidson (2005). The Human Immunodeficiency Virus (HIV). The
Florida State University.
De Maat M, Mathot R, Veldkamp A, Huitma A, Mulder J, Meenhorst P, et al
(2002). Hepatotoxicity Following Nevirapine Containing Regimens in
HIV-1-Infected Individuals. Pharmacol Res 46:295-300.
Departemen Kesehatan Republik Indonesia (2006). Pedoman Pelayanan
Kefarmasian Untuk Orang Dengan HIV/AIDS (ODHA). Direktorat Bina
Farmasi Komunitas dan Klinik Depkes RI.
Departemen Kesehatan Republik Indonesia (2007). Pedoman Nasional Terapi
Antiretroviral; Pedoman Tatalaksana Klinis dan Infeksi HIV pada Orang
Dewasa dan Remaja, Edisi Kedua.
Departemen Kesehatan Republik Indonesia (2011). Pedoman Nasional
Tatalaksana Klinis Infeksi HIV dan Terapi Antiretroviral Pada Orang
Dewasa. Direktorat Jenderal Pengendalian Penyakit dan Penyehatan
Lingkungan Depkes RI.
Dinas Kesehatan Provinsi Kepulauan Riau (2012). Profil Kesehatan Provinsi
Kepulauan Riau Tahun 2012.
Ditjen PPM & PL Depkes RI (2013). Statistik Kasus HIV/AIDS di Indonesia
Dilapor s/d Desember 2013.Jakarta:Departemen Kesehatan RI.
42

43

Djoerban, Zubairi (2007). HIV/AIDS di Indonesia. Dalam: Aru W. Sudoyo. Buku

Ajar Ilmu Penyakit Dalam, Jilid III, Edisi IV. Jakarta: FKUI.
Faucy, Anthony S., dan Lane, H. Clifford (2008). Human Immunodeficiency
Virus Disease: AIDS and Related Disorder. Dalam: A.S. Fauci. Harissons
Principles of Internal Medicine, 17th ed [e-book]. New York: McGraw-Hill.
Chap.182.
Felissa R. Lashley, Jerry D. Durham (2009). The Person With HIV/AIDS: Nursing
Perspectives. Springer Publishing Company.
Harvey, Richard (2007). Retrovirus and AIDS. Dalam: Richard A Harvey.
Microbiology 2nd Edition [e-book]. Baltimore: Lippincott Williams &
Wilkins. 295-303.
Havlir DV, Currier JS (2003). Complications of HIV infection and antiretroviral
therapy. Top HIV Med.;11:8691.
Hernandez L, Gilson I, Jacobson J, Affi A, Puetz T, Dindzans V (2001).
Antiretroviral Hepatotoxicity in HIV-Infected Patients. Aliment Pharmacol
Ther. 15:1627-1632.
Highleyman L (2012). Liver Toxicity Uncommon with Modern Antiretroviral
Drugs, but Hugher Risk for HIV/HCV Coinfected.
Hooshyar D, Napravnik S, Miller W, Eron J (2006). Effect of Hepatitis C coInfection on Discontinuitatum and Modification of Initial HAART in
Primary HIV Care. AIDS.
Jawetz M; Adelbergs (2005). Mikrobiologi Kedokteran. edisi 23. Alih Bahasa:
Huriwati Hartanto dkk. Jakarta, Penerbit Buku Kedokteran ECG.
Johnshon S, Chan J, Bennett C (2002). Hepatotoxicity After Prophylaxis With a
Nevirapine-Containing Antiretroviral Regimen. Ann Intern Med. 137:146147.

44

Kalyesubula R, Kagimu M, Opio KC (2011). Hepatotoxicity from FirstLine

Antiretroviral Theraphy: an Experience from a Resource Limited Setting.
African Health Science. 11(1): 1623
Kathryn M Chu, Andrew M Boulle, Nathan Ford (2010). Nevirapine-Associated
Early Hepatotoxicity: Incidence, Risk Factors, and Associated Mortality in
a Primary Care ART Programme in South Africa. South African Medical
Unit, Mdecins Sans Frontires, Johannesburg, South Africa.
Katzung, B (2004). Basic and Clinical Pharmacology, 8 th Edition; 1130-1155,
USA; Mc.Graw Hill Companies.Inc.
Kee, Joyce LeFever (2008). Pedoman Pemeriksaan Laboratorium dan Diagnostik.
Jakarta : EGC.
Kementrian Kesehatan Republik Indonesia (2011). Pedoman Interpretasi Data
Klinik. Direktorat Bina Pelayanan Kefarmasian dan Alat Kesehatan
Kemenkes RI.
Kumar V, Cotran RS, Robbins SL (2007). Buku Ajar Patologi. 7 th ed , Vol. 1.
Jakarta: Penerbit Buku Kedokteran EGC.
Lapau, Buchari (2012). Metode Penelitian Kesehatan. Jakarta: Yayasan Pustaka
Obor.
Lee WM (2003). Drug-induced hepatotoxicity. N Engl J Med; 349:47485.
Leith J, Piliero P, Storfer S, Mayers D, Hinzmann R (2005). Appropriate Use of
Nevirapine for Long-Term Therapy. J Infect Dis.1;192(3): 545-6.
Murphy, R (2003). Defining the Toxicity Profile of Nevirapine and Other
Antiretroviral Drugs. Journal of Acquired Immune Deficiency Syndrome;
34;S15-20.

45

Notoadmodjo, Soekidjo (2010). Metodologi Penelitian Kesehatan. Jakarta: Rineka

Cipta.
Nunez MJ. Martin-Carbonero L, Moreno V, Valencia E, Gracia-Samaniego J, et al
(2006). Impact of Antiretroviral Treatment-Related Toxicities on Hospital
Admissions in HIV-Infected Patients. AIDS Res Hum Retroviruses.
22:825-829.
P2PL Dinas Kesehatan Kota Batam (2010). Kejadian Kasus HIV & AIDS dan
Kematian HIV & AIDS di Kota Batam Tahun 2006-2009.
Palella F, Baker R, Moorman A, Chmiel J, Brooks J, et al (2006). Mortality in The
Highly Active Antiretroviral Therapy Era: Changing Causes of Death And
Desease in The HIV Outpatient Study. J Acquired Immune Deficiency
Syndrome., 43: 27-34.
Podolsky, Isselbacher (2002). Tes Diagnostik pada Penyakit Hati. Dalam:
Harrison Prinsip-prinsip Ilmu Penyakit Dalam. Edisi 13. Volume 4. Jakarta
:Penerbit Buku Kedokteran EGC
Pollard RB, Robinson P, Dransfield K (1998). Safety Profile of Nevirapine, A
Nonnucleoside Reverse Transcriptase Inhibitor for The Treatment of
Human Immunodeficiency Virus Infection. Clin Ther. 20(6): 1071-92.
Ramadian, O (2010). Pengaruh Efek Samping Antiretroviral Lini Pertama
Terhadap Adherens ODHA di Layanan Terpadu Rumah Sakit Cipto
Mangunkusumo Jakarta, Podiksus HIV/AIDS.
Sacher, McPerson (2002). Tinjauan Klinis Hasil Pemeriksaan Laboratorium. Edisi
11. Jakarta : Penerbit Buku Kedokteran EGC.
Sanne I, Mommeja-Marin H, Hinle J, Bartlett J, Lederman M, Maartens G, et al
(2005). Severe Hepatotoxicity Associated With Nevirapine Use in HIVInfected Subjects. J Infect Dis 2005; 191;825-829.
Siswanto, dkk (2013). Metodologi Penelitian Kesehatan dan Kedokteran.
Yokyakarta : Bursa Ilmu.

46

Sulkowski MS (2004). Drug-induced Liver Injury Associated with Antiretroviral

Therapy that Includes HIV-1 Protease Inhibitors. Clin Infect Dis; 38:90-97.
WHO. Global Summary of the AIDS Epidemic (2012). Dalam: Core
Epidemiological Slides HIV/AIDS Estimates WHO. 2013 [ diakses Juli
2014].
http://www.unaids.org/en/media/unaids/contentassets/documents/epidemio
logy/2013/gr2013/201309_epi_core_en.pdf
Wit FW, Weverling GJ, Weel J, Jurriaans S, Lange JM (2002). Incidence of and
Risk Factors for Severe Hepatotoxicity Associated with Antiretroviral
Combination Therapy. J Infect Dis. 1; 186(1): 23-31.
Wood E, Hogg RS, Yip, Harigan PB (2003). Effect of Medication Adherence on
Survival of HIV Patient Who Start HAART When CD4+ cell Count 200240 cell/L. Ann Intern Med.
Wondemagegn M, Gidey B, Chernet A, Alem G, Abera B (2013). Hepatotoxicity
and associated risk factors in HIV-infected patients receiving antiretroviral
therapy at Felege Hiwot Referral Hospital, Bahirdar, Ethiopia. Ethiop J
Health Sci.:217-26.